• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GPNMB 高表达预示头颈部鳞状细胞癌预后不良。

High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.

机构信息

The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China.

Department of Oral and Maxillofacial Head Neck Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan, China.

出版信息

Histol Histopathol. 2019 Jul;34(7):803-810. doi: 10.14670/HH-18-084. Epub 2019 Jan 11.

DOI:10.14670/HH-18-084
PMID:30632601
Abstract

Glycoprotein non-metastatic protein B (GPNMB) is a transmembrane glycoprotein that is highly expressed in several malignancies compared with its expression in matched healthy tissues. The aim of this study was to investigate the clinical characteristics and prognostic value of GPNMB expression in tumor tissue derived from a cohort of patients with head and neck squamous cell carcinoma (HNSCC). GPNMB expression in human HNSCC, oral dysplasia and normal mucosal tissue was evaluated by immunohistochemistry (IHC). The correlations of GPNMB expression with the clinical characteristics of HNSCC were assessed by one-way ANOVA and t test analyses. Survival data were analyzed using Kaplan-Meier analysis and the Cox proportional hazards model. GPNMB was highly expressed in HNSCC tissue compared with dysplasia and normal mucosal tissue. Additionally, a high level of GPNMB expression in HNSCC was associated with poor prognosis (P<0.01). In the analysis of tumor-node-metastasis (TNM) staging, a high GPNMB expression level in HNSCC tissue, as well as metastatic lymph node tissue, correlated with an advanced N stage. In conclusion, GPNMB was overexpressed in human HNSCC tissue and predicted poor prognosis in human HNSCC tissue. In addition, GPNMB expression was closely correlated with N stage in patients with HNSCC.

摘要

糖蛋白非转移性蛋白 B(GPNMB)是一种跨膜糖蛋白,与匹配的健康组织相比,在几种恶性肿瘤中高表达。本研究旨在探讨 GPNMB 在头颈部鳞状细胞癌(HNSCC)患者肿瘤组织中的表达的临床特征和预后价值。通过免疫组织化学(IHC)评估 GPNMB 在人 HNSCC、口腔发育不良和正常黏膜组织中的表达。通过单因素方差分析和 t 检验分析评估 GPNMB 表达与 HNSCC 临床特征的相关性。使用 Kaplan-Meier 分析和 Cox 比例风险模型分析生存数据。与发育不良和正常黏膜组织相比,GPNMB 在 HNSCC 组织中高表达。此外,HNSCC 中高水平的 GPNMB 表达与预后不良相关(P<0.01)。在肿瘤-淋巴结-转移(TNM)分期分析中,HNSCC 组织和转移性淋巴结组织中高 GPNMB 表达水平与 N 期较晚相关。总之,GPNMB 在人 HNSCC 组织中过度表达,并预测人 HNSCC 组织中的预后不良。此外,GPNMB 表达与 HNSCC 患者的 N 期密切相关。

相似文献

1
High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.GPNMB 高表达预示头颈部鳞状细胞癌预后不良。
Histol Histopathol. 2019 Jul;34(7):803-810. doi: 10.14670/HH-18-084. Epub 2019 Jan 11.
2
Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.LAMTOR5 的高表达预示着不良预后,并与头颈部鳞状细胞癌的淋巴结转移相关。
Int J Med Sci. 2019 Jun 2;16(6):783-792. doi: 10.7150/ijms.33415. eCollection 2019.
3
Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.头颈部鳞状细胞癌原发灶和淋巴结转移的潜在影像学靶点。
Am J Otolaryngol. 2024 Jul-Aug;45(4):104298. doi: 10.1016/j.amjoto.2024.104298. Epub 2024 Apr 16.
4
GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.头颈部鳞状细胞癌中 GPNMB 阳性细胞——其在癌症干性、治疗抵抗和转移中的作用。
Pathol Oncol Res. 2022 Aug 19;28:1610450. doi: 10.3389/pore.2022.1610450. eCollection 2022.
5
Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.评估抗氧化网络蛋白作为头颈部癌症患者的新型预后生物标志物。
Oral Oncol. 2020 Dec;111:104949. doi: 10.1016/j.oraloncology.2020.104949. Epub 2020 Aug 12.
6
Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma.IFIT1 和 IFITM3 在头颈部鳞状细胞癌中的表达及预后价值。
Am J Clin Pathol. 2020 Apr 15;153(5):618-629. doi: 10.1093/ajcp/aqz205.
7
Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.GPNMB的过表达预示着上皮性卵巢癌的不良预后。
Arch Gynecol Obstet. 2018 May;297(5):1235-1244. doi: 10.1007/s00404-018-4699-3. Epub 2018 Feb 10.
8
Data-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinoma.基于数据的头颈部鳞状细胞癌抗体药物偶联物靶点的优先级排序。
Oral Oncol. 2018 May;80:33-39. doi: 10.1016/j.oraloncology.2018.03.005. Epub 2018 Mar 27.
9
Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).评估原发性头颈部鳞状细胞癌中癌症干细胞标志物的表达,显示醛脱氢酶(ALDH1A1)的预后价值。
Eur J Pharmacol. 2020 Jan 15;867:172837. doi: 10.1016/j.ejphar.2019.172837. Epub 2019 Dec 5.
10
BP180 Is a Prognostic Factor in Head and Neck Squamous Cell Carcinoma.BP180 是头颈部鳞状细胞癌的预后因素。
Anticancer Res. 2021 Feb;41(2):1089-1099. doi: 10.21873/anticanres.14867.

引用本文的文献

1
GPNMB Expression Associates with Inferior Prognosis in Patients with Small Cell Lung Cancer.GPNMB表达与小细胞肺癌患者的不良预后相关。
J Cancer. 2024 Mar 31;15(10):2960-2970. doi: 10.7150/jca.92661. eCollection 2024.
2
Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma.GPNMB、EGFR、p-PI3K 和 Ki-67 在食管鳞癌患者中的预后价值。
Anal Cell Pathol (Amst). 2022 Aug 31;2022:9303081. doi: 10.1155/2022/9303081. eCollection 2022.
3
GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.
头颈部鳞状细胞癌中 GPNMB 阳性细胞——其在癌症干性、治疗抵抗和转移中的作用。
Pathol Oncol Res. 2022 Aug 19;28:1610450. doi: 10.3389/pore.2022.1610450. eCollection 2022.
4
GITR agonistic stimulation enhances the anti-tumor immune response in a mouse model of ESCC.GITR 激动性刺激增强了 ESCC 小鼠模型中的抗肿瘤免疫反应。
Carcinogenesis. 2022 Oct 22;43(9):908-918. doi: 10.1093/carcin/bgac064.
5
Theranostic near-infrared-IIb emitting nanoprobes for promoting immunogenic radiotherapy and abscopal effects against cancer metastasis.用于促进免疫放疗和抗肿瘤转移的远红外 IIb 发射纳米探针的治疗诊断一体化
Nat Commun. 2021 Dec 9;12(1):7149. doi: 10.1038/s41467-021-27485-0.
6
Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.糖蛋白非转移性黑色素瘤蛋白 B:自身免疫性疾病中的关键介质和新兴治疗靶点。
FASEB J. 2020 Jul;34(7):8810-8823. doi: 10.1096/fj.202000651. Epub 2020 May 23.